There is a lot of media talk about "finding the cure for cancer". A cure implies certainty that the cancer has been removed and will not come back. There is no such certainty with any therapy. The best that therapies can achieve is to remove all evidence of cancer. Then the patient has to wait and see if the cancer recurs. With the XYTOS Cancer Treatment (XPDT), we often improve a patient's symptoms and diagnostic test values, and we often remove all evidence of cancer. Since a significant number of our patients have metastatic cancer, and other treatments have failed, we feel that our results are very significant.

There is an argument that XPDT is more likely to "cure" cancer than other therapies. Conventional cancer therapies have limited repeatability. Surgery cannot be repeated indefinitely. Each time surgery is performed the patient loses healthy tissue. Radiation therapy is damaging, and cannot be repeated very often. Chemotherapy will eventually fail too work. Different drugs can be used, usually with increasing toxicity and decreasing tolerance by both the body and the patient.

For the XYTOS Cancer treatment (XPDT), we do not believe that there is a limit (other than cost) to the number of times it can be repeated. Patients who are successfully treated with XPDT can choose to repeat the treatment every few years, for preventive purposes. If the tumor recurs, they can repeat the therapy, hopefully with the same success as before.

No one can guarantee that their treatment has "cured "cancer, so patients need regular monitoring. This also applies to our treatment (XPDT). With some of our patients' cancers, we are in areas where we have limited data with respect to results. We have posted on this website evidence of the success that we have achieved in a number of different cancers and we have identified the types of cancers that we have had the greatest success treating. For example, we treated a lady with a grade IV breast cancer and now she has no evidence of cancer as shown by PDD. Although the results would vary between patients, this is a significant accomplishment under any standards. We of course use (PDD) a sensitive diagnostic tool to confirm our results. Using (PDD) our patient need less monitoring than usual. Another patient with mesothelioma is much improved, something, which doesn't happen with other therapies.

Conservative patients may choose to get occasional additional rounds of therapy, no matter what monitoring shows. There is little downside other than a possible waste of money and time; but evidence as demonstrated that It may well be worthwhile using XPDT for prevention. People in the peak cancer ages of 50 plus with no known cancer may choose to get XPDT every few years as a preventive measure.